Scientists decode breast cancer DNA to unlock better treatments
NCT ID NCT02022202
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study looked at the DNA of breast tumors from 140 patients to understand why some cancers are destroyed by standard chemotherapy and others are not. Researchers analyzed genetic changes in the tumors and compared them to normal DNA. The goal is to find new drug targets and improve future cancer therapies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could point toward more personalized breast cancer treatments based on genetic mutations.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly lead to new therapies, and results may not apply to all breast cancer patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Mayo Clinic campus in Arizona
Scottsdale, Arizona, 85259, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can sound waves replace the scalpel for breast tumors?
- Could a bank of breast cancer samples unlock new treatments?
- Less radiation for breast cancer? a trial tests a smarter, response-based approach
- Proton beam aims to spare healthy tissue after breast cancer surgery
- Can walking flush out hidden toxins? new study tests exercise against PFAS